SC 13G Filing

Company

Barinthus Biotherapeutics plc.

Filed

November 5, 2021

Accession Number

0000929638-21-001315

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →